R. Paul Johnson
- Ophthalmology top 1%
- Molecular Biology
- Immunology top 10%
- Hematology top 5%
- Oncology top 10%
- Co-authors
- W. Conrad LilesAnnabelle A. OkadaAnn Sullivan BakerDonald J. D’AmicoMichael RosenzweigMaryAnn DeMariaMargaret A. GoodellStephen Grupp
- Topics
- HIV Research and Treatment (7 papers)Immune Cell Function and Interaction (4 papers)Virus-based gene therapy research (3 papers)
- Cited by
- OphthalmologyVirologyHematology
- Partner nations
- United StatesGermanyAustria
In The Last Decade
R. Paul Johnson
15 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Ophthalmology 589
- Molecular Biology 519
- Immunology 341
- Hematology 319
- Oncology 304
Countries citing papers authored by R. Paul Johnson
This map shows the geographic impact of R. Paul Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Paul Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Paul Johnson more than expected).
Fields of papers citing papers by R. Paul Johnson
This network shows the impact of papers produced by R. Paul Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Paul Johnson. The network helps show where R. Paul Johnson may publish in the future.
Co-authorship network of co-authors of R. Paul Johnson
This figure shows the co-authorship network connecting the top 25 collaborators of R. Paul Johnson. A scholar is included among the top collaborators of R. Paul Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Paul Johnson. R. Paul Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 61 | |
| 2 | 40 | |
| 3 | 5 | |
| 4 | 56 | |
| 5 | 12 | |
| 6 | 16 | |
| 7 | 21 | |
| 8 | 21 | |
| 9 | T-lymphopoietic capacity of cord blood-derived CD34+ progenitor cells. | 7 |
| 10 | 117 | |
| 11 | 3 | |
| 12 | Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple speciesbreakdown → | 879 |
| 13 | Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. | 330 |
| 14 | 294 | |
| 15 | 36 |
About R. Paul Johnson
R. Paul Johnson is a scholar working on Virology, Otorhinolaryngology and Immunology, having authored 15 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (7 papers), Immune Cell Function and Interaction (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Ophthalmology (589 citations), Virology (228 citations) and Hematology (319 citations). R. Paul Johnson has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include W. Conrad Liles, Annabelle A. Okada, Ann Sullivan Baker, Donald J. D’Amico, Michael Rosenzweig, MaryAnn DeMaria, Margaret A. Goodell, Stephen Grupp, Richard C. Mulligan and G Paradis. Their work appears in journals such as Nature Medicine, The EMBO Journal and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.